Table 1.
Demographic data on patients in cohort.
| Overall (n = 454) | Intensive (n = 16) | Weekly (n = 121) | Biweekly (n = 65) | Monthly (n = 126) | Bimonthly (n = 126) | Pvalue | |
|---|---|---|---|---|---|---|---|
| Male | 46.5% | 50.0% | 48.3% | 55.4% | 46.8% | 39.7% | 0.32 |
| Mean Age Visit Date | 38.6 | 41.0 | 36.4 | 36.7 | 39.2 | 40.7 | 0.01 |
| Mean Age Started COAT | 35.6 | 40.9 | 36.4 | 35.5 | 36.1 | 32.6 | 0.01a |
| White | 94.3% | 87.5% | 92.3% | 95.1% | 94.2% | 96.8% | 0.42 |
| Black | 3.6% | 6.3% | 6.0% | 1.6% | 3.3% | 2.4% | |
| Other | 2.1% | 6.3% | 1.7% | 3.3% | 2.5% | 0.8% | |
| Insurance | < 0.00 | ||||||
| Public | 74.0% | 93.8% | 90.8% | 84.6% | 75.2% | 48.8% | |
| Private | 24.9% | 6.3% | 8.4% | 13.9% | 24.0% | 49.6% | |
| Self-Pay/Other | 1.1% | 0.0% | 0.8% | 1.5% | 0.8% | 1.6% | |
| Mean Buprenorphine Dose | 12.3 mg | 13.4 | 12.0 | 11.9 | 12.7 | 12.4 | 0.30 |
a
Statistically significant difference between Bimonthly & Intensive.